Enzo Biochem Reports Strong Fiscal Fourth Quarter Results
October 09, 2014
Enzo Biochem Awarded Patent for Novel Vectors Involving Gene Therapy Treatments for Cancer, Virus Infections and Genetic Diseases
October 07, 2014
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter Results Friday, October 10, 2014 at 8:30 AM E.T.
October 06, 2014
Thomas C Wright, MD, World Recognized Women’s Health Sciences Authority, Joins Enzo Biochem’s Clinical Division
July 31, 2014
Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies
July 29, 2014
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health
July 02, 2014
from PR Newswire
Enzo Biochem Reports Strong Third Fiscal Quarter Results
June 09, 2014
Enzo Biochem Schedules Teleconference to Discuss Third Quarter Results Tuesday, June 10, 2014 at 8:30 AM E.T.
June 03, 2014
Enzo Biochem Unit Partners with Innate Pharma S.A. to Validate Key System for Antibody Drug Conjugate Development
May 30, 2014
Enzo Biochem Announces Settlement Agreement with Affymetrix
April 24, 2014
Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results Wednesday, March 12, 2014 at 8:30 AM E.T.
March 10, 2014
Enzo Biochem’s Clinical Lab and Nuclea Biotechnologies Join to Market New Test for Certain High Risk Breast Cancer Patients
February 18, 2014
Enzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis Review
February 03, 2014
Trend Analysis Report - Brandywine Realty Trust (NYSE:BDN), YRC Worldwide, Inc. (NASDAQ:YRCW), Enzo Biochem, Inc. (NYSE:ENZ), XOMA Corp (NASDAQ:XOMA)
January 07, 2014
Birmingham, West Midlands -- (SBWIRE) -- 01/07/2014 -- Value Penny Stocks issues special report on Brandywine Realty Trust (NYSE:BDN), YRC Worldwide, Inc. (NASDAQ:YRCW), Enzo Biochem, Inc. (NYSE:ENZ),... Read More
Enzo Biochem Announces Upcoming Litigation Schedule
January 07, 2014
Enzo Biochem and Flagship Biosciences Partner to Provide Tissue-Based Companion Diagnostics Offering Complete Solution for In Situ Hybridization Development to Pharmaceutical Companies
December 11, 2013
Enzo Biochem Reports First Fiscal Quarter Results
December 10, 2013
Enzo Biochem Schedules Teleconference to Discuss First Quarter Results Wednesday, December 11, 2013 at 8:30 AM E.T.
December 09, 2013
Enzo Biochem Announces Study in Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, a Deadly Human Disease with No Effective Treatment Options, to Presence of a Monkey Virus
November 15, 2013
Enzo Biochem and Sequenom Partner to Market Key Sequenom Laboratories Prenatal Testing Service
October 29, 2013
Manny Villafana, Founder of St. Jude Medical, to Deliver Keynote Presentation During Online Conference Read More
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here